M. Herrman

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models

Z. An, S. Abbot, Swapna Panuganti, 2022, Clinical & translational immunology.

Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma

Z. An, M. Tabrizizad, A. Lucas, 2021, Journal for ImmunoTherapy of Cancer.

Neutralizing Antibodies to Epstein Barr Virus in the Rhesus Macaque Animal Model and in Humans

M. Herrman, 2015 .

Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques

Fred Wang, C. Quink, M. Herrman, 2015, Journal of Virology.

Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptase-specific CTL clones.

T. Harrer, E. Harrer, J. Kalden, 1999, Journal of immunology.

ClonesHIV-1-Reverse Transcriptase-Specific CTL Patients Due to Clonal Expansion of Biased TCR Repertoire in HIV-1-Infected

T. Harrer, E. Harrer, W. Kolowos, 1999 .

198 Innate-enhanced chimeric adaptors (CAd): A newly-described approach for augmenting potency of γδ T cell immunotherapy

M. Tabrizizad, Gauri Lamture, B. Aftab, 2022, Regular and Young Investigator Award Abstracts.

119 ADI-002: an IL-15 armored allogeneic ‘off-the-shelf’ Vδ1 gamma delta CAR T cell therapy for solid tumors targeting glypican-3 (GPC3)

A. Lucas, Z. An, M. Tabrizizad, 2021, Journal for ImmunoTherapy of Cancer.